Kahn RS, Silverman BL, DiPetrillo L, Graham C, et al. A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension. Schizophr Res 2021;232:45-53.
PMID: 34015555